'Boston scientific stent recall' presentation slideshows

Critical Path Research: Getting New Technology from Bench to Bedside A Device Perspective FDA Science Board November

Critical Path Research: Getting New Technology from Bench to Bedside A Device Perspective FDA Science Board November 5, 2004. Dan Schultz Director, CDRH. Establish reasonable assurance of the safety and effectiveness of medical devices marketed in the U.S. Role of FDA. HHS/FDA/CDRH.

658 views • 32 slides